Clinical Trial Update: Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions [NA]

View source ↗

Summary

A completed bioequivalency study of imipramine pamoate 75 mg capsules under fasted conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• imipramine pamoate 75 mg capsules (imipramine pamoate)

Snippet

Sponsor: Roxane Laboratories | Conditions: Depression | NA | Status: COMPLETED | Results posted: 2014-01-15